Maria L. Sbaraglini

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition.

Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 23, 2025

Discovery of Trypanosoma cruzi Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening.

Discovery of Trypanosoma cruzi Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening.

Journal: Journal of chemical information and modeling

Published: May 12, 2025

Synthesis and biological evaluation of new antiseizure compounds derived from valproic acid.

Synthesis and biological evaluation of new antiseizure compounds derived from valproic acid.

Journal: Future medicinal chemistry

Published: May 25, 2023

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies.

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies.

Journal: Beilstein journal of nanotechnology

Published: April 05, 2023

A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity.

A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity.

Journal: Journal of computer-aided molecular design

Published: September 15, 2022

Structure-Based Virtual Screening Identifies Novobiocin, Montelukast, and Cinnarizine as TRPV1 Modulators with Anticonvulsant Activity In Vivo.

Structure-Based Virtual Screening Identifies Novobiocin, Montelukast, and Cinnarizine as TRPV1 Modulators with Anticonvulsant Activity In Vivo.

Journal: Journal of chemical information and modeling

Published: June 13, 2022

Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation.

Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation.

Journal: Frontiers in chemistry

Published: March 30, 2022

Nebulization of a polyelectrolyte-drug system for systemic hypertension treatment.

Nebulization of a polyelectrolyte-drug system for systemic hypertension treatment.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 24, 2021

Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers.

Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers.

Journal: Frontiers in chemistry

Published: August 31, 2020

Parabens inhibit hNaV 1.2 channels.

Parabens inhibit hNaV 1.2 channels.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 05, 2020

A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors.

A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: October 18, 2019

Trypanosoma cruzi Virulence Factors for the Diagnosis of Chagas' Disease.

Trypanosoma cruzi Virulence Factors for the Diagnosis of Chagas' Disease.

Journal: ACS infectious diseases

Published: September 21, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026